Medical Rationale
Gabapentin and pregabalin, widely prescribed for service-connected neuropathic pain, produce cognitive impairment through GABAergic and calcium channel modulation in the central nervous system. These medications bind voltage-gated calcium channels (alpha-2-delta subunit), reducing excitatory neurotransmitter release in the hippocampus and prefrontal cortex — regions critical for memory and executive function. Studies demonstrate dose-dependent cognitive impairment: at standard neuropathic pain doses (gabapentin 1800-3600mg/day, pregabalin 300-600mg/day), patients show measurable deficits in verbal memory, processing speed, and attention. The "gabapentin fog" is well-recognized clinically and can impair occupational functioning independently of the underlying pain condition.
Key Studies
Salinsky MC et al. (2005) Epilepsia (gabapentin cognitive effects); Hindmarch I et al. (2005) Psychopharmacology (pregabalin cognitive and psychomotor effects); Zaccara G et al. (2008) Epilepsia (antiepileptic drug cognitive side effects).
Filing Tips
Neuropsychological testing showing cognitive deficits correlating with medication initiation. Prescribing records showing gabapentin/pregabalin prescribed for service-connected pain condition. Neurology or psychiatry nexus letter connecting medication side effects to cognitive impairment. Document impact on work performance — inability to concentrate, memory lapses, word-finding difficulty. VA rates cognitive impairment under DC 9326 or as a medication side effect claim.